Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) – Equities researchers at Roth Capital boosted their Q2 2025 earnings estimates for shares of Fortress Biotech in a research report issued on Tuesda… [+3929 chars]...
Read moreFortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) traded down 0.6% on Wednesday . The stock traded as low as $6.60 and last traded at $6.75. 20,760 shares were traded during trading, an increas… [+1202 chars]...
Read moreWolverine Trading LLC purchased a new position in shares of Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Secu… [+3624 chars]...
Read moreMIAMI, May 30, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (Fortress), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value … [+6915 chars]...
Read moreAmarantus BioScience (OTCMKTS:AMBS – Get Free Report) and Journey Medical (NASDAQ:DERM – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the tw… [+6270 chars]...
Read morePalatin Technologies (NYSE:PTN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap manufacturing companies, but which is the better business? We will con… [+6011 chars]...
Read more